- Home
- SLVM vs BCRX Comparison
SLVM vs BCRX Comparison
Compare SLVM & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLVM | BCRX |
|---|---|---|
| Founded | 1898 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paper | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | SLVM | BCRX |
|---|---|---|
| Price | $49.78 | $6.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $54.00 | $20.82 |
| AVG Volume (30 Days) | 263.3K | ★ 4.9M |
| Earning Date | 02-12-2026 | 02-23-2026 |
| Dividend Yield | ★ 3.57% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.36 | N/A |
| Revenue | ★ $3,431,000,000.00 | $599,816,000.00 |
| Revenue This Year | N/A | $40.20 |
| Revenue Next Year | N/A | $6.36 |
| P/E Ratio | $11.56 | ★ N/A |
| Revenue Growth | N/A | ★ 45.38 |
| 52 Week Low | $37.52 | $6.00 |
| 52 Week High | $82.04 | $11.31 |
Technical Indicators
Market Signals| Indicator | SLVM | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 49.06 | 39.07 |
| Support Level | $49.04 | $6.59 |
| Resistance Level | $51.56 | $7.15 |
| Average True Range (ATR) | 1.66 | 0.37 |
| MACD | -0.16 | -0.04 |
| Stochastic Oscillator | 45.59 | 12.34 |
Price Performance
Historical ComparisonAbout SLVM Sylvamo Corporation
Sylvamo Corp is an uncoated papers company with a broad portfolio of top-tier brands and low-cost, large-scale paper mills, it produces uncoated freesheet (UFS) for paper products such as cut size and offset paper, as well as market pulp. The company offers Copy and Printer papers, Commercial Printing papers, Converting papers and Specialty papers. It operates in three geographical segments: Europe, Latin America, and North America. Key revenue is generated from North America.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.